aTyr Pharma | LIFE - Net Income


aTyr Pharma reported $24.56M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Ardelyx USD -407K 562K Dec/2025
aTyr Pharma USD 24.56M 50.3M Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Cipla INR 6.76B 6.75B Dec/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
CSL USD 401M 96.5M Dec/2025
Curis USD 19.36M 31.16M Dec/2025
Galapagos EUR 782.15M 984.26M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Grifols EUR 114.37M 34.03M Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
United Therapeutics USD 364.3M 25.6M Dec/2025
Xoma USD -17.24M 33.23M Sep/2024